.svg){kind=icon}
Our approach to sustainability
Investing in our people
Our people bring distinct skills, expertise, ideas and passion to work every day
Our approximately 90,000 employees are the driving force behind our efforts to deliver on our mission to accelerate innovation for a healthier world.
EMPLOYEE VALUE PROPOSITION (EVP)
Connecting with our people
Connecting over 90,000 talented and passionate people across different business units and regions is fundamental to our success. We are focused on building an environment that provides the tools, resources, and support our employees need to collaborate and innovate.
Over the course of 2025, we continued to embed tour EVP across all parts of our business.
Over the course of 2025, we continued to embed tour EVP across all parts of our business.
Brandon Hall Awards
Awards for talent excellence
We received independent recognition from the Brandon Hall Group for our focus on building the skills and experiences our employees need to be successful.
Gold award for Best New Hire Onboarding Program and Bronze award for Best Unique or Innovative Talent Acquisition Program for our IQVIA Enterprise Onboarding
Bronze awards for Best Custom Content and Best Unique or Innovative Learning & Development Program for Orchestrated Customer Engagement Digital Campaign Designer.
Gold award for Best New Hire Onboarding Program and Bronze award for Best Unique or Innovative Talent Acquisition Program for our IQVIA Enterprise Onboarding
Bronze awards for Best Custom Content and Best Unique or Innovative Learning & Development Program for Orchestrated Customer Engagement Digital Campaign Designer.
Examples of how we support our communities
We continued our long-running partnership with Race for 7 coordinated by the Organization for Rare Diseases India. More than 7,000 rare diseases have been documented so far, affecting one in 20 of the Indian population. The event aimed to encourage 7,000 people to run seven kilometers to build awareness of rare diseases and to raise funds to develop new treatments.
The IQVIA Clinical Supply Chain Management group worked with our partners at the Coalition for Epidemic Preparedness Innovations to donate surplus face masks, gloves, lab coats, and other personal protective equipment. We donated a shipping container full of PPE to the organization to support their essential research and other healthcare activities to one identified beneficiary: Medical Research Council Unit The Gambia.
Last year, we continued our support for the annual Light the Night Walk for The Leukemia & Lymphoma Society. Each year, around 140 walks take place across the U.S. and Canada to raise funds for research into blood cancer cures. Our annual fundraising campaign ran through September and October, promoting employee engagement and raising awareness of blood cancer.
Last year:
- IQVIA chaired the North Carolina activities.
- 245 employees registered for the walk and committed to raising funds.
Funds raised by individual IQVIA participants and through corporate sponsorship will help support critical cancer research.
Each year, we offer employees a volunteer day: IQVIA Day
Our Employees can use the day to support a local community project, charity or non-profit organization of their choosing. Employees can participate either individually or as part of a group initiative led by IQVIA.
Advancing public health
Creating positive impact for people and the planet through our business
Working with global and local partners to deliver insights, support research and catalyze access to vital treatments for the patients and populations that need them most.
Accelerating optimized clinical trial delivery
IQVIA adopts a molecule-to-market approach to trial set-up and management. We seek to create efficient and reliable protocol designs that minimize complexity and reduce patient and investigator burden, while optimizing desired outcomes.
Our approach enables us to anticipate changing global regulatory requirements and adapt trial protocols as needed.
Sickle Cell Anemia
Our end-to-end approach helped to inform trial design for patients with sickle cell anemia. Using real-world data, we reduced the burden of trials on sites and patients, enabling more efficient recruitment and trial conduct. This work spanned globally, including in the Middle East and sub-Saharan Africa, resulting in a more than two-fold increase in global recruitment rates.
Community Health Institute
In the U.S., we are working with clinical trial sponsors and community health networks to bring trials closer to patients through our Community Health Initiative. Patients are commonly only informed about relevant clinical trials when referred to hospitals and specialist healthcare settings, meaning many are not informed of relevant, potentially life-saving trials that may be applicable to them. The Community Health Initiative aims to locate more trials in primary care, broadening the number of trial sites, patient access and awareness of trials, and expanding care options for patients.
Last year, we launched several workstreams to identify solutions that will drive clinical research into primary care settings across key therapy areas, starting with the central nervous system.
Last year, we launched several workstreams to identify solutions that will drive clinical research into primary care settings across key therapy areas, starting with the central nervous system.
Global Public Health
IQVIA is uniquely placed to help tackle some of the world’s biggest health challenges in partnership with governments, healthcare providers, non-governmental organizations and the biopharma industry.
We combine our scale and comprehensive datasets with local knowledge, expertise, tools and operations to develop the appropriate response for all research.
We combine our scale and comprehensive datasets with local knowledge, expertise, tools and operations to develop the appropriate response for all research.
Innovative technology supports better direct-to-patient data collection
Enabling better healthcare decision-making requires innovation to increase real-world research without adding to the burden on clinicians or patients. The use of mobile and web technology could provide the answer by facilitating direct-to-participant data collection.
IQVIA’s new platform, IQVIA Health Research Space, was designed with patient input to ensure a user-friendly and engaging experience.
Its flexibility offers participants a convenient way to share information, reduces the need for site involvement and supports ongoing engagement for multi-year studies.
AI delivers tangible trial benefits
AI generates new insights and recommendations, helping to increase clinical trial efficiency at all stages, from trial design to data submission.
Driving environmental impact
We are committed to reducing our impact on the environment
We focus on the areas where we have the greatest opportunity to effect positive change.
GHG emissions reduction goals
IQVIA is committed to achieving a 90% reduction in our scope 1, 2 and 3 greenhouse gas emissions by 2050 from a 2019 baseline, with science-based targets validated by the Science Based Targets initiative. We focus on the highest-emission areas of our value chain and therefore where we can make the greatest difference. Learn more on page 70 in our report.
Sustainability in our laboratories
Laboratories are resource intensive spaces, using more energy and water than our office facilities and producing higher volumes of waste. Because of this, we collaborate with the non-profit My Green Lab (MGL) to reduce the environmental impact of our labs.
MGL certification is considered the industry gold standard for sustainability best practice in laboratories, and it is recognized by the United Nations’ Race to Zero campaign as a key measure of progress towards a sustainable net zero future.
Through this collaboration, we now have all labs certified across the UK, Europe, Asia and the Americas, and more than 150 IQVIA employees trained as MGL ambassadors to initiate sustainability improvement projects across our labs.
Waste reduction: Re-engineering our clinical trial test kits services
Re-engineering our clinical trial test kit services is one of our biggest opportunities to reduce waste. We are reducing single-use plastic packaging and optional items from our test kits, such as single-use needles and pipettes.
- Last year, we removed almost 3 metric tons of single-use plastic outer packaging for clinical trial test kits from our supply chain at our Edinburgh and Marietta central labs.
- We are transitioning to recycled cardboard boxes, replacing bleached virgin cardboard within our kit supply chain.
- We have identified further opportunities to reuse dry ice in frozen shipments, expanded polystyrene and gel packs. We continue to look for more sustainable options throughout our clinical trial test kit service.
To reduce unnecessary waste of our test kits, we are using our advanced analytics to improve trial materials management. This aims to match supply to demand more precisely and prevent unnecessary surplus of kits.
We have been working in partnership with clinical trial sites to advise, educate and guide positive behaviors with regards to kit ordering, with the aim to reduce the risk of waste in our supply chain in the future. We partner with our customers to reduce waste rates of kits through the advocacy of external initiatives such as Kits4Life. Read more about our operational waste reduction efforts on page 77 in our report.
We have been working in partnership with clinical trial sites to advise, educate and guide positive behaviors with regards to kit ordering, with the aim to reduce the risk of waste in our supply chain in the future. We partner with our customers to reduce waste rates of kits through the advocacy of external initiatives such as Kits4Life. Read more about our operational waste reduction efforts on page 77 in our report.
Honors
External awards and recognition
Through our relentless focus on the delivery of our mission we continue to be recognized as a leader across the healthcare industry.
2024 Sustainability Report
Our commitment to our sustainability efforts is unwavering because we believe creating a healthier world takes more than just healthcare.
Supporting documents
As part of our continued commitment to transparency, IQVIA has made its most recent EEO-1 Component 1 report publicly available in the link below. The EEO-1 Component 1 report is a mandatory annual data collection by the U.S. Equal Employment Opportunity Commission that requires all private sector employers with 100 or more employees, and federal contractors with 50 or more employees meeting certain criteria, to submit demographic workforce data, including data by race/ethnicity, sex and job categories.